Related Experiment Video

Updated: Sep 3, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

8.9K

The role of dual-specificity phosphatase 3 in melanocytic oncogenesis

Emmanouil Chousakos1, Nikolaos Katsoulas1, Nikolaos Kavantzas1

  • 11st Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Experimental Dermatology
|July 28, 2022
PubMed

Insights

Dual-specificity phosphatase 3 (DUSP3) regulates key cellular processes in melanocytic tumors. Understanding DUSP3

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Dual-specificity phosphatase 3 (DUSP3), also known as Vaccinia H1-related phosphatase, is a protein tyrosine phosphatase.
  • DUSP3 regulates diverse cellular functions via dephosphorylation of numerous substrates.
  • Altered DUSP3 expression or activity is linked to neoplasm development and progression.

Purpose of the Study:

  • To review DUSP3's role in benign and malignant melanocytic oncogenesis.
  • To synthesize current knowledge on DUSP3's regulatory targets in melanoma.
  • To provide a foundation for future research on melanocytic tumor therapeutics.

Main Methods:

  • Literature review synthesizing existing research on DUSP3.
  • Analysis of DUSP3 interactions and substrate roles in melanocytic oncogenesis.
  • Examination of pathways regulating cellular growth, cycle, survival, and migration.

Main Results:

  • DUSP3 substrates are implicated in critical oncogenic pathways including cell growth, proliferation, and apoptosis.
  • DUSP3 influences genomic stability, cell adhesion, and migration in tumor melanocytes.
  • Evidence suggests DUSP3 is a significant factor in oncogenesis and a potential therapeutic target.

Conclusions:

  • DUSP3 plays a crucial role in melanocytic oncogenesis by regulating key cellular processes.
  • Further research into DUSP3's mechanisms can inform the development of novel therapeutic strategies for melanoma.
  • DUSP3 represents a promising target for the management and treatment of melanocytic tumors.
Keywords:
DUSP3VHRdual-specificitymelanomanevioncogeneoncogenesisoncosuppressorphosphatase

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

15.9K
The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression11:02

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression

Published on: August 3, 2011

49.9K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K